| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 5,190,837 | 138,595,000 | 54.99% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 2,872,130 | 77,548,000 | 30.77% | ||
| 3 | Opko Health, Inc. | 14,000,000 | 21,399,000 | 8.49% | PRN | |
| 4 | BIOMARIN | 90,215 | 9,451,000 | 3.75% | ||
| 5 | MERRIMACK PHARMACEUTI | 3,500,000 | 5,027,000 | 1.99% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-16-009582, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
